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OBJECTIVE: To investigate the prevalence of obstructive sleep apnea in patients with ischemic stroke and to evaluate the ef-
fectiveness of nasal continuous positive airway pressure treatment. 
METHODS: Overnight polysomnography was performed by a computerized system in 19 subjects with ischemic stroke. Patients 
with an apnea-hypopnea index ≥ 5 were considered to have obstructive sleep apnea. The appropriate level of continuous positive 
airway pressure for each patient was determined during an all-night continuous positive airway pressure determination study. Attended 
continuous positive airway pressure titration was performed with a continuous positive airway pressure auto-titrating device.
RESULTS: Obstructive sleep apnea prevalence among patients with ischemic stroke was 73.7%. The minimum SaO2 was sig-
nificantly lower, and the percent of total sleep time in the wake stage and stage 1 sleep was significantly longer in patients with 
obstructive sleep apnea. In two patients with severe obstructive sleep apnea, we observed a decrease in the apnea-hypopnea index, 
an increase in mean wake time, mean SaO2, and minimum SaO2, and alterations in sleep structures with continuous positive airway 
pressure treatment.
CONCLUSION: As the diagnosis and treatment of obstructive sleep apnea is of particular importance in secondary stroke preven-
tion, we suggest that the clinical assessment of obstructive sleep apnea be part of the evaluation of stroke patients in rehabilitation 
units, and early treatment should be started.
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INTRODUCTION 
Stroke is an important cause of mortality and a major 
cause of disability among adults, leading to considerable 
economic and social problems. The most effective means 
of diminishing stroke-related burden is by reducing the 
incidence of first-time and recurrent stroke. Therefore, 
recognizing and treating modifiable risk factors are of 
particular importance. Besides the well-known modifiable 
risk factors, such as hypertension, diabetes mellitus, 
heart disease, smoking, excessive alcohol use, and 
hypercholesterolemia,1 obstructive sleep apnea (OSA) is 
emerging as an important risk factor.2 
Obstructive sleep apnea syndrome (OSAS), characterized 
by repeated episodes of upper airways obstruction during 
sleep that lead to significant hypoxemia, is a prevalent 
disorder particularly among middle-aged men, though 
its existence in women is increasingly recognized. 
Epidemiological studies estimate that 2 to 5% of the 
population meets the minimal diagnostic criteria (snoring, 
witnessed apnea and excessive daytime sleepiness), and 
two community-based studies have found that about 2% of 
women and 4% of men were affected by OSAS.3 We recently 
reported a female patient for whom severe OSAS was the 
cause of fibromyalgia syndrome, which was totally resolved 
with the treatment of OSAS.4 OSAS is characterized by 
periods of breathing cessation (apnea) and periods of 626
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reduced breathing (hypopnea). Both types of events have 
similar pathophysiology and are generally considered equal 
with respect to their impact on patients. There are several 
methods of quantifying the severity of the disorder, such as 
measuring the number of apneas and hypopneas per hour 
of sleep (the apnea-hypopnea index, AHI), the severity of 
oxygen desaturation during sleep, or the severity of the 
most commonly associated symptom, daytime sleepiness.3,5 
OSAS is also associated with increased risk of stroke and 
other cardiovascular diseases. There are various mechanisms 
that contribute the increased risk of stroke and other 
cardiovascular diseases, such as increased sympathetic 
activity, endothelial dysfunction, elevated fibrinogen levels, 
increased in vivo platelet activation during sleep, alteration 
of in vitro platelet aggregability, hypercoagulability, 
and decreased cerebral blood flow in sleep apnea (SA) 
patients.6-11 The increased carotid wall thickness observed in 
patients with severe sleep apnea may also increase the risk 
of stroke.12 Therefore, the treatment of OSA is important 
since it might prevent these consequences of the disease. 
The accepted and highly effective treatment of OSA is nasal 
continuous positive airway pressure (CPAP).2 It is reported 
that stroke patients with OSA can also be effectively treated 
with CPAP.13,14 
This study aimed to investigate the OSA prevalence in 
ischemic stroke patients and to evaluate the effectiveness of 
the CPAP treatment in this group. 
METHODS
Patients
Among 55 stroke patients hospitalized for rehabilitation, 
25 patients with ischemic stroke at the subacute and chronic 
stages were selected. Exclusion criterion disqualified patients 
with previous diagnoses of sleep disordered-breathing, 
current CPAP treatment, unstable comorbidities (cardiac 
or respiratory failure), or ventilatory dependence. As a 
result, the study was completed with 19 patients (13 men, 
6 women) with ischemic stroke who were able to give 
informed consent. The study was approved by the local 
ethics committee. Stroke was diagnosed according to the 
World Health Organization criteria,15 and cerebral lesion 
was confirmed by computerized tomography or magnetic 
resonance imaging in all patients. A detailed history was 
taken before examinations, including previous transient 
ischemic attacks (TIA) or strokes, concomitant diseases that 
are among modifiable risk factors of stroke (hypertension, 
ischemic cardiovascular diseases (CVD), diabetes, and 
hypercholesterolemia), former or current smoking history, 
alcohol consumption, and complaints of habitual snoring, 
excessive daytime sleepiness, and witnessed apneas before 
stroke. Habitual snoring, excessive daytime sleepiness, and 
witnessed apneas were considered clinical signs of OSA. 
Snoring was considered habitual if it was reported to occur 
often or always. Daytime sleepiness was evaluated using the 
Epworth Sleepiness Scale (ESS) with scores > 10 regarded 
as excessive.16 The patients’ heights and weights were 
measured, and body mass index (BMI) was calculated in 
kg/m2. An overnight polysomnography was performed in all 
patients. Patients diagnosed with moderate to severe OSA 
were further evaluated for CPAP treatment.
Sleep study 
Overnight polysomnography (PSG) was performed in 
all patients by a computerized system (Somnostar alpha; 
Sensormedics, USA) that included the following variables: 
electrooculogram (2 channels), electroencephalogram 
(4 channels), electromyogram of submental muscles (2 
channels), electromyogram of the anterior tibialis muscles 
of both legs (2 channels), and electrocardiogram and airflow 
(with an oro-nasal thermistor). Chest and abdominal efforts 
(2 channels) were recorded using inductive plethysmography, 
and arterial oxyhemoglobin saturation (SaO2: 1 channel) 
was recorded by pulse oximetry with a finger probe. The 
recordings were conducted at a paper speed of 10 mm/s, 
and sleep stages were scored according to the standard 
criteria of Rechtschaffen and Kales.17 Arousals were scored 
according to accepted definitions,18 and the arousal index 
(ARI) was calculated as the number of arousals per hour of 
sleep. Apnea was defined as a complete cessation of airflow 
≥ 10 s. Hypopnea was defined as a reduction of > 50% in 
either: one of the three respiratory signals, the airflow signal, 
or either respiratory or abdominal signals of respiratory 
inductance plethysmography, with an associated fall of ≥ 
3 % in oxygen saturation or an arousal.19 Each apnea and 
hypopnea was classified as obstructive, central, or mixed, 
based on the presence or absence of respiratory effort.2 It is 
also recommended that mixed apnea be included as a part of 
OSA. The diagnosis criteria for central sleep apnea syndrome 
is five or more central apneas per hour of sleep.20 The apnea-
hypopnea index (AHI) was defined as the number of apneas 
and hypopneas per hour of sleep. Patients with AHI ≥ 5 were 
considered to have OSA. Patients with AHI 5 to 15 were 
diagnosed as mild, 15-30 were moderate and greater than 
30 were severe OSA.19 Patients with OSA were compared 
to patients without OSA. Patients with sleep disorders 
other than OSA, such as upper airway resistance syndrome, 
periodic leg movement syndrome, or narcolepsy, were 
excluded. Patients with moderate to severe OSA were further 
evaluated for CPAP treatment. The therapy and possible side 627
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effects were explained to the patients, and in patients who 
agreed to use CPAP treatment, the appropriate level of CPAP 
for each patient was determined during an all-night CPAP 
pressure determination study. A polysomnographic study 
was performed with the same setup as the diagnostic study, 
except that nasal CPAP was applied during sleep. Attended 
CPAP titration was performed with the CPAP auto-titrating 
device (AutoSet; Resmed, Sydney, Australia) on the second 
night of the study in our hospital. Patients were prescribed 
the use of the CPAP device (Vector Plus CPAP devices; 
Hoffrichter, Germany) that automatically turned on when the 
mask was removed. We measured compliance by the mean 
rate of CPAP use (hours per day). Acceptable duration was 
considered ≥ 4 h/night. 
Statistical analysis
A computer-based statistics program (SPSS version 
11.5) was used to evaluate the study data. The differences 
between groups were assessed using the Fisher exact test 
for categorical variables and Mann-Whitney U test for the 
ordinal variables. The results are expressed as mean ± SD. 
The significance level was set at p < 0.05. 
RESULTS
Obstructive sleep apnea was diagnosed in 14 of the 19 
stroke patients (73.7%), of whom eight had mild (mean AHI: 
9.6 ± 3.5), two had moderate (mean AHI: 20.6 ± 1.0), and 
four had severe (mean AHI: 83.1 ± 41.9) OSA. The mean 
AHI of OSA (+) patients was 32.2 ± 39.3; the mean AHI 
of OSA (-) patients was 2.0 ± 0.9. The mean total counts 
of apneas-hypopneas were 121.8 ± 120.6 in the OSA (+) 
group (central 7.8 ± 8.6, mixed 9.3 ± 19.4, obstructive 104.6 
± 108.7) and 10.8 ± 4.9 in the OSA (-) group (central 1.4 
± 1.1, mixed 0, obstructive 9.4 ± 5.8). The mean central 
apnea counts did not differ statistically between groups 
with AHI ≥ 5 and < 5 (Table 1). There were no statistically 
significant differences between the OSA (+) and OSA (-) 
stroke patients in mean ages, mean time elapsed from the 
Table 1 - Characteristics and polysomnography data of stroke patients with and without obstructive sleep apnea (OSA)
OSA (n=14) No OSA (n=5) p
Age (years) 63.3±12.8 55.8±14.7 NS*
Male gender (%) 8 (57.1) 5 (100) NS
Time after stroke onset (months) 11.4±15.7 18.1±19.2 NS
Body Mass Index (kg/m2) 25.8±3.6 25.4±5.9 NS
Total apnea-hypopnea count (mean± SD) (range) 121.8 ± 120.6 (28-382) 10.8 ± 4.9 (6-19) P=0.001
Obstructive 104.6 ± 108.7 (16-373) 9.4 ± 5.8 (3-19) P=0.002
Mixed 9.3 ± 19.4 (0-70) 0 (0) P=0.014
Central 7.8 ± 8.6 (0-30) 1.4 ± 1.1 (0-3) NS
Prior history of TIA or stroke (%) 6 (42.9) None NS
Concomitant diseases** (%) 10 (71.4) 4 (80) NS
Smoking history (%) 6 (42.9) 5 (100) p=0.045
Alcohol history (%) 1 (7.1) 1 (20) NS
Habitual snoring (%) 9 (64.3) 1 (20) NS
Excessive daytime sleepiness or witnessed apneas (%) 10 (71.4) 2 (40) NS
Mean sleep period time (minutes) 401.4±42.1 391.5±43.0 NS
Total sleep time (minutes) 268.2±64.2 331.7±30.0 NS
Sleep efficiency (%) 63.6±16.3 78±6.6 NS
Arousal index 12.2 ±8.9 10.2±4.4 NS
Mean SaO2*** (%) 90.2±2.4 92.2±1.9 NS
Mean wake SaO2 (%) 94.1±2.5 94±1.8 NS
Minimum SaO2 (%) 78.5±7.9 88.2±3.1 p=0.005
Percent of total sleep time in Stage Wake (%) 32.5±16.6 14.8±7.4 p=0.014
Percent of total sleep time in Stage 1 (%) 14.1±10.8 6.9±3.7 p=0.044
Percent of total sleep time in Stage 2 (%) 53.6±15.4 58.7±13.2 NS
Percent of total sleep time in Stage 3 (%) 5.2±3.2 5.9±4.9 NS
Percent of total sleep time in Stage 4 (%) 14.4±15.3 13.4±11.9 NS
Percent of total sleep time in Stage REM (%) 12.6±7.2 15.1±10.5 NS
* NS: Not significant; ** Concomitant diseases: Hypertension, ischemic cardiovascular diseases, diabetes or hypercholesterolemia; *** SaO2: Oxygen 
saturation628
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onset of stroke, and BMI (Table 1). There were also no 
statistically significant differences between OSA (+) and 
OSA (-) patients in mean sleep period time, total sleep time, 
sleep efficiency, arousal index, mean SaO2, and mean wake 
SaO2. There were also no statistically significant differences 
in the percent of total sleep time in stage 2, stage 3, stage 
4 non-rapid eye movement (NREM), and stage rapid eye 
movement (REM) sleep. Minimum SaO2 was significantly 
lower in OSA (+) than in OSA (-) patients, while the percent 
of total sleep time in the wake stage and stage 1 NREM 
sleep were significantly longer in OSA (+) than in OSA 
(-) patients. Among OSA (+) patients, eight were (57.1%) 
male, six had (42.9%) a prior history of TIA or CVA, ten had 
(71.4%) concomitant diseases, six (42.9%) were former or 
current smokers, one (7.1%) was a former alcohol user, nine 
defined habitual snoring (64.3%) and ten (71.4%) had other 
clinical signs (excessive daytime sleepiness or witnessed 
apneas). Among the five OSA (-) patients, all were males, all 
were former or current smokers, four had (80%) concomitant 
diseases, two (40%) had clinical signs of OSA, one (20%) 
was a former alcohol user, one (20%) defined habitual 
snoring and none had a prior history of TIA or CVA,. Among 
all these parameters, only the frequency of former or current 
smoking history was higher in OSA (-) patients (χ2= 4.93, 
p=0.045), but this is likely a misleading result due to the 
small study population. The characteristics and PSG data of 
the patients with and without OSA are given in Table 1. 
Treatment with CPAP
Only two patients with severe OSA (ages 86 and 65 
years; AHI of 144.1 and 62.3) agreed to use the CPAP 
treatment. The polysomnography data of these patients 
before and after the CPAP treatment are given in Table 2. 
DISCUSSION
In this study, OSA was diagnosed in 73.7% of stroke 
patients. The minimum SaO2 was significantly lower in 
patients with OSA than without OSA, and the percentages 
of total sleep time in wake stage and stage 1 NREM sleep 
were significantly longer. 
The OSA frequency of 73.7% in these ischemic stroke 
patients was exceedingly high when compared with its 
prevalence of 2% in women and 4% in men in the middle-
aged population. This frequency was also above the range 
of 12.5-23% reported for the control groups of previously 
published studies in stroke or TIA patients.21-23 When 
compared with the previously reported frequencies (36.7-
79%) of SA in stroke or TIA patients,7,13,21-31 our result 
is closer to the upper limit. The discrepancy between the 
reported frequencies may have resulted from differences 
in the intervals between the onset of stroke and sleep 
recordings, stroke subtypes, sleep study methods, and sleep 
apnea definitions between these studies.. Most of these 
studies evaluated the SA prevalence in acute stroke or TIA 
syndromes, some of these studies included both ischemic 
and hemorrhagic types, and most of them used AHI > 10 for 
diagnosis of SA instead of > 5. Additionally, not all of these 
studies used in-laboratory comprehensive PSG recordings, 
which is the accepted test for diagnosing and determining 
the severity and treatment of OSA.32 Therefore, it can be 
assumed that some mild SA patients might have been 
overlooked in previous work, and the SA prevalence may 
be higher, especially in the acute stages of stroke or TIA. 
Another possible explanation for why our result is closer 
to the upper limit of reported frequencies though all our 
Table 2 - Polysomnography data of patients before and after 
continuous positive airway pressure treatment
Before CPAP After CPAP
Total Apnea-Hypopnea Count Patient 1 347 5
Patient 2 382 121
Apnea-Hypopnea Index Patient 1 144.1 1.0
Patient 2 62.3 31.6
Arousal Index Patient 1 10 10.2
Patient 2 33.4 16.4
Mean wake SaO2* (%) Patient 1 88 96
Patient 2 91 94
Mean SaO2 (%) Patient 1 85 94
Patient 2 86 90
Minimum SaO2 (%) Patient 1 71 84
Patient 2  59 83
Sleep efficiency (%) Patient 1 32 71
Patient 2 77 59
Percent of total sleep time 
in Stage Wake (%)
Patient 1 67.2 26.7
Patient 2 22.6 39.4
Percent of total sleep time 
in Stage 1 (%)
Patient 1 40.8 7.7
Patient 2 10.6 3.9
Percent of total sleep time 
in Stage 2 (%)
Patient 1 59.2 60.0
Patient 2 55.2 50.7
Percent of total sleep time 
in Stage 3 (%)
Patient 1 0 5.8
Patient 2 5.6 9.1
Percent of total sleep time 
in Stage 4 (%)
Patient 1 - 7.2
Patient 2 14.0 2.8
Percent of total sleep time 
in Stage REM (%)
Patient 1 - 19.3
Patient 2 14.7 33.5
* SaO2: Oxygen saturation629
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patients were in subaute or chronic stages of ischemic stroke, 
the sensitive detection methods and lower diagnostic criteria 
may have identified more mild cases of OSA. 
Central apneas are also observed in patients with stroke. 
Central periodic breathing (CPB) most frequently results 
from congestive heart failure and is characterized by 
cyclic fluctuations in breathing drive, such as hyperpneas 
alternating with apneas or hypopneas in a gradual waxing 
and waning fashion. CPB may also develop in stroke 
patients without cardiopulmonary disease and disturbed 
consciousness.30 Obstructive sleep apneas predominate in the 
acute phases of stroke, whereas central apneas are associated 
with an altered state of consciousness, brain edema, and 
brainstem localization of ischemia. During recovery after 
stroke, the incidence of central apneas diminishes, whereas 
obstructive apneas remain at a similar level.31 Hermann et 
al. reported that 58% of 31 first-ever stroke patients had 
sleep-disordered breathing; 9.7% of these presented as CPB, 
and all others presented as OSA.30 Rola et al. evaluated 55 
patients with ischemic stroke and 15 patients with TIA for 
sleep related breathing disorders (SRBD), and they found 
that SRBD were present in 36 patients (65.4%) with stroke 
and ten patients (66.6%) with TIA. Obstructive apneas 
were the most frequent apnea-related episodes in both 
stroke and TIA patients (77.6 ± 12.6% and 80.5 ± 13.6, 
respectively). Central apneas amounted to 13.2 ± 9.6% of 
stroke patients and 10.5 ± 8.6% of TIA patients.31 Likewise, 
obstructive events were the predominating type, and central 
apnea-hypopneas constituted only 6.4% of the total apnea-
hypopnea count in sleep apnea patients in our study group; 
none of the patients in this study group satisfied the criteria 
of central apnea syndrome. 
In our study, all patients were ischemic stroke patients, 
and the mean time elapsed from the stroke onset was 11 
months (minimum 6 weeks), representing the stable phase 
of stroke. The results of this study confirm the study of 
Szücs et al., who reported that SA frequency and severity 
were unchanged three months later in most ischemic stroke 
patients, while greatly improved in hemorrhagic stroke 
patients. Moreover, the study presumed that hemorrhagic 
strokes lead more often to central apneas. In contrast, OSA 
itself is a probable risk factor for ischemic stroke.27
In our patients with OSA, the minimum SaO2 was 
significantly lower, and the percent of total sleep time in 
the wake stage and stage 1 NREM sleep were significantly 
longer, as expected. Apnea-related episodes lower the SaO2 
during sleep, and OSA patients spent more time in the wake 
and transition stages between awake and sleep during the 
night due to apneas and arousals. Sleep efficiency was also 
decreased in OSA patients, though we did not demonstrate 
a statistically significant difference. The other statistically 
significant variable was the smoking history; however, 
surprisingly, the frequency of smoking history was higher in 
OSA (-) patients than OSA (+) patients, although this was 
likely a misleading result due to the small study population. 
Although not statistically significant, the presence of habitual 
snoring and other clinical signs of OSA were also higher 
in OSA patients in accordance with the literature.2,21,24,29 
Although we could not demonstrate any statistically 
significant differences in these variables, this was likely 
a result of our small sample size. However, since the in-
laboratory comprehensive PSG recordings technique used in 
this study was detailed, not readily available, and expensive, 
we had to conduct our study with a limited number of 
patients. These factors also contributed to the absence of 
an appropriate control group from the population, which 
was a limitation of our study. Since the history of habitual 
snoring and other clinical signs of OSA were present before 
stroke, we can presume that OSA might be a preceding risk 
factor for stroke, in accordance with the opinion that OSA 
constitutes a significant risk for cardiovascular diseases 
including stroke.2,7-12
Whether OSA is a cause or consequence of stroke, its 
management is of particular importance in secondary stroke 
prevention.13 It was shown that stroke patients with OSA can 
also be effectively treated with CPAP.13,14 A reversal of the 
blood coagulability, increase in oxygen saturation, increase 
in cerebral blood flow response to hypoxia, reduction in 
mean nocturnal blood pressure, and improvements in sleep 
structures are observed with CPAP therapy.9,10,14,33 In our 
study, only two patients with severe OSA agreed to use 
the CPAP treatment. Although it is impossible to draw 
a conclusion about the effectiveness of CPAP with two 
patients, we wished to share the results of these patients. A 
decrease in AHI, increases in mean wake time, mean SaO2, 
and minimum SaO2, and alterations in sleep structures were 
observed with the CPAP treatment. In one of the patients, 
sleep efficiency was obviously increased, and the percentage 
of total sleep time in the wake stage and stage 1 NREM 
sleep were decreased with the CPAP treatment. Before the 
CPAP treatment, the patient spent nearly no time in stage 3/4 
NREM sleep (deep sleep) and REM sleep. After the CPAP 
treatment, the patient began sleeping for longer periods at 
the deep sleep and REM sleep stages. These changes in 
sleep structure were consistent with the study that reported 
that CPAP significantly reduced stage 1/2 NREM sleep and 
markedly increased stage 3/4 NREM and REM sleep on 
the first night of treatment.34 The CPAP treatment was well 
tolerated, and home treatment was continued in this patient. 
However, in the other patient, the percent of total sleep time 
in stage 1, stage 2, and deep sleep decreased, while the 
percent of total sleep time in the wake stage and REM sleep 630
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increased. This second patient also experienced decreased 
sleep efficiency and did not continue the CPAP treatment 
at home due to the discomfort caused by the device. The 
obvious improvement in one of the patients confirms the 
effectiveness and usefulness of CPAP therapy13,14 in stroke 
patients with OSA.
To conclude, the OSA prevalence was fairly high in our 
small sample of ischemic stroke patients. As the diagnosis and 
treatment of OSA is of particular importance in secondary 
stroke prevention, we suggest that the clinical assessment 
of OSA be a part of the evaluation of stroke patients in 
rehabilitation units. Since CPAP is an effective treatment of 
OSA and provides clinical improvements in compliant stroke 
patients, early treatment should be started. 
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